UNSPSC 51141500: Anticonvulsants

This classification denotes drugs used to prevent seizures or reduce their severity.

UNSPSC 51141500 Anticonvulsants is a Class code that encompasses pharmaceutical products procured by state and local health agencies, though recent solicitations tagged to this code show substantial divergence from anticonvulsants specifically. Seminole County, Florida is procuring Naloxone and Safe Drug Deactivation Systems through competitive bidding, while the Texas Health and Human Services Commission has issued a Request for Information on direct-to-manufacturer prescription programs and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administered by the Minnesota Department of Administration's Office of State Procurement has solicited generic multi-source pharmaceuticals and over-the-counter products for distribution across state and local government facilities. The issuing bodies include county health departments (Seminole County), state health and human services agencies (Texas HHS), and cooperative purchasing entities serving multiple states (MMCAP). These procurement vehicles reflect broader state and local investment in pharmaceutical supply chains, emergency response products, and cost management through direct manufacturer relationships and multi-state pooling.

Geographically, recent activity centers on Florida, Texas, and Minnesota, with MMCAP's footprint extending to Oregon. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026; due July 26, 2023) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026; response due April 3, 2026) to gather vendor capabilities on direct-to-manufacturer prescription models, and MMCAP's RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers with awards effective July 1, 2026. The code shows limited recent activity explicitly tied to anticonvulsants; the tagged opportunities instead reflect emergency response pharmaceuticals, wholesale distribution models, and state-level pharmacy benefit program modernization.